Empresa Synaptogenix, Inc. Other OTC
Acciones
SNPX
US87167T1025
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 01/01/18 |
Daniel Alkon
PSD | President | 81 | 07/12/20 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 01/10/13 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 01/01/18 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 14/11/16 |
Joshua Silverman
CHM | Chairman | 53 | 04/08/16 |
Director/Board Member | 50 | 13/12/18 | |
William Singer
BRD | Director/Board Member | 82 | 23/08/13 |
Daniel Alkon
PSD | President | 81 | 07/12/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 233 230 | 1 206 807 ( 97,86 %) | 0 | 97,86 % |
Acción B | 0 | 3 000 | 0 | 0 |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+67,53 % | 63,85 mil M | |
-0,77 % | 41,83 mil M | |
+45,66 % | 40,65 mil M | |
-10,72 % | 27,12 mil M | |
+13,30 % | 26,52 mil M | |
-22,79 % | 18,69 mil M | |
+4,70 % | 12,73 mil M | |
+24,10 % | 12,11 mil M | |
+27,41 % | 12,07 mil M |